Clarient, Inc. (NASDAQ:CLRT)

stock of the day

Oversold

Trending in the right direction - given the investment climate they are managing cash well and able to maintain funding.

With a proprietary diagnostic system that detects the most accurate results in the industry, this company is taking market share quickly and with a small sales force at that!. Clarient is a relatively small start up company in the diagnostic arena that is starting to see the return on its investments. With a few quarters showing positive figures on its balance sheet, these guys are going to boooom!!! Clarient was established by a team of industry guru's from Roche, Safeguard Scientifics, Immucor and AmeriPath alike.

+ 50 % Revenues for several quarters
60 % Insider Holdings
executing on plan to get cash flow positive and reach profitability soon
chart breakout

Strong in oncology field

CLARIENT,INC Will be cash positive in the fourth quarter and will have double dighit growth in year 2007.

Clarient is well on its way to becoming a profitable company, has a niche market with its products and services, and is as close to a 'gimme' speculative winner as you'll ever see in your lifetime.

I don't do speculative plays, but this one is much more a growth play- CLRT will take off within a year unless all hell breaks loose.

Just turning the corner for becoming profitable. Expect this stock to increase over 100%

Turned up on a screen for companies with hideous balance sheets. Current ratio has been dwindling and recently slipped to 0.74. Cash flow and earnings negative for a decade+, only question is if they'll be able to keep finding financing. Total current assets 13,324, total current liabilities 17,961. In Dec ’05 quarter total current assets were 16,042 , total current liabilities 8,958, with cash dropping from 9,333 to 2,620 over the same time. Deferred long term liability charges have popped up on the balance sheet this past year. The biggest dogs in the field, Quest Diagnostics and Laboratory Corp. are both making a lot of money and eating up more market share. Throw in a delistment scare from July ’06 which lasted until November when it finally broke $1 for 10 straight days, and you’ve got a decent bet on an implosion.

Caveats:

1) I don’t take on infinite risk so I never actually short stock, if I’m going to bet against a company I use puts. This is an experiment to see if I can detect companies that are teetering on bankruptcy.
2) They’ve gone a decade without making a dime and have still found a way to stay alive.
3) Comerica just raised their credit limit from 8.5M to 12M.

Speculative but high quality medical diagnostics company with promising product.

Just read some stuff today, sounded convincing.